Brief: Biomed Lublin Says Hungarian National Institute Of Pharmaceutical And Food Health Issues MA For Anti-Tuberculosis Vaccine BCG 10

Synthaverse SA

19/06/2023 07:12

June 19 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA  BML.WA :
    * HUNGARIAN NATIONAL INSTITUTE OF PHARMACEUTICAL AND FOOD
HEALTH
ISSUES MARKETING AUTHORIZATION FOR ANTI-TUBERCULOSIS VACCINE
MANUFACTURED BY COMPANY UNDER TRADE NAME ANTI-TUBERCULOSIS
VACCINE BCG 10

Source text for Eikon:  ID:nEM24j269a 
Further company coverage:  BML.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))